Novo Nordisk A/S – The Final Phase 3a Trial for IDegLira Completed, and FIAsp Approved for Phase 3 Development

BAGSVAERD, DENMARK--(Marketwire - Dec 19, 2012) - Company Announcement No 83 2012: http://hugin.info/2013/R/1666389/540820.pdf…

---

Novo Nordisk A/S – The Final Phase 3a Trial for IDegLira Completed, and FIAsp Approved for Phase 3 Development

BAGSVAERD, DENMARK--(Marketwire - December 19, 2012) - Company Announcement No 83 2012:http://hugin.info/2013/R/1666389/540820.pdfThis announcement is distributed by Thomson Reuters on behalf ofTho…

---

Novo Nordisk A/S: Share Repurchase Program

BAGSVAERD, DENMARK--(Marketwire - December 17, 2012) - Company Announcement no 82 2012:http://hugin.info/2013/R/1665610/540445.pdfThis announcement is distributed by Thomson Reuters on behalf ofThom…

---

Novo Nordisk A/S – Share Repurchase Program

BAGSVAERD, DENMARK--(Marketwire - December 10, 2012) - On 9 November 2012 Novo Nordiskinitiated a share repurchase programme in accordance with the provisions ofthe European Commission's regulation…

---